Literature DB >> 25612167

Extensive acute axonal damage in pediatric multiple sclerosis lesions.

Sabine Pfeifenbring1, Reem F Bunyan, Imke Metz, Christian Röver, Peter Huppke, Jutta Gärtner, Claudia F Lucchinetti, Wolfgang Brück.   

Abstract

OBJECTIVE: Axonal damage occurs early in multiple sclerosis (MS) and contributes to the degree of clinical disability. Children with MS more often show disabling and polyfocal neurological symptoms at disease onset than adults with MS. Thus, axonal damage may differ between pediatric and adult MS patients.
METHODS: We analyzed axonal pathology in archival brain biopsy and autopsy samples from 19 children with early MS. Lesions were classified according to demyelinating activity and presence of remyelination. Axonal density and extent of acute axonal damage were assessed using Bielschowsky silver impregnation and immunohistochemistry for amyloid precursor protein (APP), respectively. Axonal injury was correlated with the inflammatory infiltrate as well as clinical characteristics. Results were compared with data from adult MS patients.
RESULTS: Acute axonal damage was most extensive in early active demyelinating (EA) lesions of pediatric patients and correlated positively with the Expanded Disability Status Scale at attack leading to biopsy/autopsy. Comparison with 12 adult patients showed a 50% increase in the extent of acute axonal damage in EA lesions from children compared to adults, with the highest number of APP-positive spheroids found prior to puberty. The extent of acute axonal damage correlated positively with the number of lesional macrophages. Axonal density was reduced in pediatric lesions irrespective of the demyelinating activity or the presence of remyelination. Axonal reduction was similar between children and adults.
INTERPRETATION: Our results provide evidence for more pronounced acute axonal damage in inflammatory demyelinating lesions from children compared to adults.
© 2015 American Neurological Association.

Entities:  

Mesh:

Year:  2015        PMID: 25612167      PMCID: PMC4523885          DOI: 10.1002/ana.24364

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  42 in total

1.  The management of multiple sclerosis in children: a European view.

Authors:  Angelo Ghezzi; Brenda Banwell; Alexey Boyko; Maria Pia Amato; Banu Anlar; Morten Blinkenberg; Maartje Boon; Massimo Filippi; Sergiusz Jozwiak; Immy Ketelslegers; Barbara Kornek; Ming Lim; Eva Lindstrom; Congor Nadj; Rinze Neuteboom; Maria A Rocca; Kevin Rostasy; Marc Tardieu; Evangeline Wassmer; Coriene Catsman-Berrevoets; Rogier Hintzen
Journal:  Mult Scler       Date:  2010-08-04       Impact factor: 6.312

2.  Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults.

Authors:  Emmanuelle Waubant; Dorothee Chabas; Darin T Okuda; Orit Glenn; Ellen Mowry; Roland G Henry; Jonathan B Strober; Bruno Soares; Max Wintermark; Daniel Pelletier
Journal:  Arch Neurol       Date:  2009-08

Review 3.  Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.

Authors:  Hans Lassmann
Journal:  Exp Neurol       Date:  2009-10-17       Impact factor: 5.330

Review 4.  Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions.

Authors:  Brenda Banwell; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu
Journal:  Lancet Neurol       Date:  2007-10       Impact factor: 44.182

Review 5.  Multiple sclerosis in children.

Authors:  Natan Gadoth
Journal:  Brain Dev       Date:  2003-06       Impact factor: 1.961

6.  Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis.

Authors:  Mark P Gorman; Brian C Healy; Mariann Polgar-Turcsanyi; Tanuja Chitnis
Journal:  Arch Neurol       Date:  2009-01

7.  Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.

Authors:  Frederik Barkhof; Wolfgang Bruck; Corline J A De Groot; Elisabeth Bergers; Sandra Hulshof; Jeroen Geurts; Chris H Polman; Paul van der Valk
Journal:  Arch Neurol       Date:  2003-08

8.  Natural history of multiple sclerosis with childhood onset.

Authors:  Christel Renoux; Sandra Vukusic; Yann Mikaeloff; Gilles Edan; Michel Clanet; Bénédicte Dubois; Marc Debouverie; Bruno Brochet; Christine Lebrun-Frenay; Jean Pelletier; Thibault Moreau; Catherine Lubetzki; Patrick Vermersch; Etienne Roullet; Laurent Magy; Marc Tardieu; Samy Suissa; Christian Confavreux
Journal:  N Engl J Med       Date:  2007-06-21       Impact factor: 91.245

9.  Paediatric multiple sclerosis: the experience of the German Centre for Multiple Sclerosis in Childhood and Adolescence.

Authors:  Wiebke Stark; Peter Huppke; Jutta Gärtner
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

10.  The relation between inflammation and neurodegeneration in multiple sclerosis brains.

Authors:  Josa M Frischer; Stephan Bramow; Assunta Dal-Bianco; Claudia F Lucchinetti; Helmut Rauschka; Manfred Schmidbauer; Henning Laursen; Per Soelberg Sorensen; Hans Lassmann
Journal:  Brain       Date:  2009-03-31       Impact factor: 13.501

View more
  19 in total

1.  A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis.

Authors:  Xiao-Lu Yuan; Yi-Peng Zhao; Jie Huang; Jun-Chen Liu; Wen-Qian Mao; Jun Yin; Bi-Wen Peng; Wan-Hong Liu; Song Han; Xiao-Hua He
Journal:  CNS Neurosci Ther       Date:  2018-03-25       Impact factor: 5.243

2.  Sequential phases of RGC axonal and somatic injury in EAE mice examined using DTI and OCT.

Authors:  Christopher Nishioka; Hsiao-Fang Liang; Barsam Barsamian; Shu-Wei Sun
Journal:  Mult Scler Relat Disord       Date:  2018-11-13       Impact factor: 4.339

3.  Temporal and Spatial Dynamics of Astroglial Reaction and Immune Response in Cuprizone-Induced Demyelination.

Authors:  Jun An; Jun-Jun Yin; Yan He; Ruo-Xuan Sui; Qiang Miao; Qing Wang; Jie-Zhong Yu; Jing-Wen Yu; Fu-Dong Shi; Cun-Gen Ma; Bao-Guo Xiao
Journal:  Neurotox Res       Date:  2019-11-13       Impact factor: 3.911

Review 4.  Bringing the HEET: The Argument for High-Efficacy Early Treatment for Pediatric-Onset Multiple Sclerosis.

Authors:  Marisa McGinley; Ian T Rossman
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 5.  Pediatric Multiple Sclerosis: an Update.

Authors:  Scott Otallah; Brenda Banwell
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-18       Impact factor: 5.081

Review 6.  Newer Treatment Approaches in Pediatric-Onset Multiple Sclerosis.

Authors:  Gabrielle Macaron; Jenny Feng; Manikum Moodley; Mary Rensel
Journal:  Curr Treat Options Neurol       Date:  2019-09-27       Impact factor: 3.972

Review 7.  Paediatric Multiple Sclerosis: Update on Diagnostic Criteria, Imaging, Histopathology and Treatment Choices.

Authors:  I-Jun Chou; Huei-Shyong Wang; William P Whitehouse; Cris S Constantinescu
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

8.  B-cell populations discriminate between pediatric- and adult-onset multiple sclerosis.

Authors:  Alexander Schwarz; Bettina Balint; Mirjam Korporal-Kuhnke; Sven Jarius; Kathrin von Engelhardt; Alexandra Fürwentsches; Cornelia Bussmann; Friedrich Ebinger; Brigitte Wildemann; Jürgen Haas
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-12-15

9.  Pronounced Structural and Functional Damage in Early Adult Pediatric-Onset Multiple Sclerosis with No or Minimal Clinical Disability.

Authors:  Antonio Giorgio; Jian Zhang; Maria Laura Stromillo; Francesca Rossi; Marco Battaglini; Lucia Nichelli; Marzia Mortilla; Emilio Portaccio; Bahia Hakiki; Maria Pia Amato; Nicola De Stefano
Journal:  Front Neurol       Date:  2017-11-14       Impact factor: 4.003

10.  Axonal Damage in Pediatric Multiple Sclerosis.

Authors:  Nancy L Kuntz
Journal:  Pediatr Neurol Briefs       Date:  2015-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.